199 related articles for article (PubMed ID: 22195787)
1. Antitumor activity of drug loaded glycyrrhetinic acid modified alginate nanoparticles on mice bearing orthotopic liver tumor.
Zhang C; Wu Y; Liu T; Zhao Y; Wang X; Wang W; Yuan Z
J Control Release; 2011 Nov; 152 Suppl 1():e111-3. PubMed ID: 22195787
[No Abstract] [Full Text] [Related]
2. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy.
Zhang C; Wang W; Liu T; Wu Y; Guo H; Wang P; Tian Q; Wang Y; Yuan Z
Biomaterials; 2012 Mar; 33(7):2187-96. PubMed ID: 22169820
[TBL] [Abstract][Full Text] [Related]
3. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
4. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.
Chavanpatil MD; Khdair A; Panyam J
Pharm Res; 2007 Apr; 24(4):803-10. PubMed ID: 17318416
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of targeted DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')2 for treatment of hepatocellular carcinoma.
Jin C; Yang W; Bai L; Wang J; Dou K
J Control Release; 2011 Nov; 152 Suppl 1():e14-5. PubMed ID: 22195807
[No Abstract] [Full Text] [Related]
6. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
[TBL] [Abstract][Full Text] [Related]
7. Functional alginate nanoparticles for efficient intracellular release of doxorubicin and hepatoma carcinoma cell targeting therapy.
Guo H; Lai Q; Wang W; Wu Y; Zhang C; Liu Y; Yuan Z
Int J Pharm; 2013 Jul; 451(1-2):1-11. PubMed ID: 23618965
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of carboplatin biodegradable polymeric nanoparticles.
Nanjwade BK; Singh J; Parikh KA; Manvi FV
Int J Pharm; 2010 Jan; 385(1-2):176-80. PubMed ID: 19854254
[TBL] [Abstract][Full Text] [Related]
9. Formulation and cytotoxicity of doxorubicin loaded in self-assembled bio-polyelectrolyte microshells.
Tao X; Chen H; Sun XJ; Chen JF; Roa WH
Int J Pharm; 2007 May; 336(2):376-81. PubMed ID: 17223293
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antitumor activity of doxorubicin-loaded alginic-acid-based nanoparticles.
Cheng Y; Yu S; Wang J; Qian H; Wu W; Jiang X
Macromol Biosci; 2012 Oct; 12(10):1326-35. PubMed ID: 22887841
[TBL] [Abstract][Full Text] [Related]
11. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance.
Khdair A; Chen D; Patil Y; Ma L; Dou QP; Shekhar MP; Panyam J
J Control Release; 2010 Jan; 141(2):137-44. PubMed ID: 19751777
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
Khdair A; Handa H; Mao G; Panyam J
Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331
[TBL] [Abstract][Full Text] [Related]
14. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.
Pranatharthiharan S; Patel MD; Malshe VC; Pujari V; Gorakshakar A; Madkaikar M; Ghosh K; Devarajan PV
Drug Deliv; 2017 Nov; 24(1):20-29. PubMed ID: 28155331
[TBL] [Abstract][Full Text] [Related]
15. Effect of manufacturing parameters on the release profiles of casein-loaded alginate microspheres prepared by emulsification/internal gelation.
Li R; Zhang X; Shi H
J Control Release; 2011 Nov; 152 Suppl 1():e154-5. PubMed ID: 22195817
[No Abstract] [Full Text] [Related]
16. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
Wong HL; Rauth AM; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
[TBL] [Abstract][Full Text] [Related]
19. Injectable hybrid laponite/alginate hydrogels for sustained release of methylene blue.
Li Y; Santos JL; Maciel D; Tomás H; Rodrigues J
J Control Release; 2011 Nov; 152 Suppl 1():e55-7. PubMed ID: 22195924
[No Abstract] [Full Text] [Related]
20. Acid and reduction stimulated logic "and"-type combinational release mode achieved in DOX-loaded superparamagnetic nanogel.
Song M; Xue Y; Chen L; Xia X; Zhou Y; Liu L; Yu B; Long S; Huang S; Yu F
Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():354-63. PubMed ID: 27157762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
